Monoclonal Antibody Therapy in Childhood Helps Reduce Long-Term MS Disability

Retrieved on: 2024-10-02 15:52:51

Tags for this article:

Click the tags to see associated articles and topics

Monoclonal Antibody Therapy in Childhood Helps Reduce Long-Term MS Disability. View article details on hiswai:

Excerpt

Monoclonal antibody therapy during childhood vs early adulthood leads to a lower risk for higher disability levels among patients with MS.

Article found on: www.neurologyadvisor.com